{"nct_id":"NCT03194867","title":"Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) Patients","status":"COMPLETED","status_verified_date":"2024-05","start_date":"2018-02-21","start_date_type":"ACTUAL","primary_completion_date":"2023-04-05","primary_completion_date_type":"ACTUAL","completion_date":"2023-04-05","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["SNY"]}